Advertisement
We believe that the FDA, in opposing the right of people with terminalillnesses to potentially life-saving treatments, is violating the veryprinciples on which the United States of America was founded. The Declarationof Independence states, "We hold these truths to be self-evident, that all menare created equal, that they are endowed by their Creator with certainunalienable Rights that among these are Life, Liberty and the pursuit ofHappiness." These rights are fundamental to all mankind and we deplore theCourt of Appeals' support of this denial.
Advertisement
Not only are the FDA's policies delaying new products from reachingpatients but these policies have caused huge increases in medical costs. Therequired clinical trials cost an average of over eight-hundred million dollarsand can take up to ten years before a new drug is approved. Many promising newtreatments are abandoned only because of the high cost of the trials.
We also believe that the FDA in only considering the evidence from theirtrials and not all the information available is in violation of theinstructions given by the Congress in its mandating act. There are manytreatments that have been tested, approved and are widely used in othercountries and that evidence is being ignored by the FDA.
Gene therapy such as Advexin and cancer vaccines such as Provenge and GVAXare examples of important new treatments for cancer that have shown safety andeffectiveness to which access is being denied. While the FDA delays approval,patients are suffering and dying.
The Cancer Cure Coalition will be supporting the Abigail Alliance in itsappeal of this decision to the Supreme Court of the United States. We willalso be seeking action by the Congress to correct this wrong.
This release was issued through eReleases(TM). For more information,visit http://www.ereleases.com.Press Contact: Charles A. Reinwald, President Cancer Cure Coalition, Inc. 914-723-0468 E-mail: [email protected] http://www.cancercurecoalition.org
SOURCE Cancer Cure Coalition, Inc.
